Article
Prognostic value of FLT3 mutations among different cytogenetic subgroups in acute myeloid leukemia.
Cancer - 15 May 2011
Santos Fabio P S, Jones Dan, Qiao Wei, Cortes Jorge E, Ravandi Farhad, Estey Elihu E, Verma Dushyant, Kantarjian Hagop, Borthakur Gautam
Abstract excerpt
BACKGROUND: The impact of FMS-like tyrosine kinase 3 (FLT3) mutations and mutation burden among cytogenetic subgroups of patients with acute myeloid leukemia (AML) other than normal karyotype (NK) AML is unclear. METHODS: Patients with newly diagnosed AML were divided among 3 cytogenetic subgroups: core binding factor (CBF) AML, NK-AML, and poor-risk AML. RESULTS: In total, 481 patients were included: 13% had,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
